title: Subclinical hypothyroidism: Should we treat?
abstract: Subclinical hypothyroidism (also known as compensated hypothyroidism or mild hypothyroidism) is a condition associated with a raised serum concentration of thyroid stimulating hormone (TSH) but a normal serum free thyroxine (FT4). It is common, affecting about 10% of women above the age of 55 years. Autoimmunity is the commonest cause of subclinical hypothyroidism. About 2.5% of patients with subclinical hypothyroidism progress to clinically overt hypothyroidism each year; the rate of progression is higher in patients with thyroid autoantibodies and higher thyroid stimulating hormone levels. However, thyroid function normalises spontaneously in up to 40% cases. Only a small minority of patients with subclinical hypothyroidism have symptoms, and the evidence to support that levothyroxine ameliorate the symptoms in these patients is weak. Subclinical hypothyroidism in younger patients (<65 years) is associated with an increased risk of coronary heart disease, heart failure and cerebrovascular disease. The risk increases with increasing levels of thyroid stimulating hormone, and is particularly high in patients with TSH levels ≥10.0 mu/L. There is lack of evidence from randomised controlled trials as to whether levothyroxine treatment can prevent these risks, although a large observational study of the UK general practice research database has shown that levothyroxine may reduce the risk of coronary heart disease in younger patients (<70 years). Therefore, the decision whether to treat or not to treat subclinical hypothyroidism should be made after careful consideration of the patient's age, the presence of symptoms, the presence of thyroid antibodies and other risk factors such as cardiovascular disease.
authors.affiliation: 1 Department of Endocrinology, Royal Devon & Exeter Hospital Foundation Trust, Exeter, UK.
authors.forename: Christopher
authors.initials: C
authors.lastname: Redford
authors.affiliation: 1 Department of Endocrinology, Royal Devon & Exeter Hospital Foundation Trust, Exeter, UK.|2 Department of Endocrinology, University of Exeter Medical School, Exeter, UK.
authors.forename: Bijay
authors.initials: B
authors.lastname: Vaidya
mesh_terms: D058070:Asymptomatic Diseases / Q000628:therapy*; D002318:Cardiovascular Diseases / Q000209:etiology; D006801:Humans; D007037:Hypothyroidism / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D001523:Mental Disorders / Q000209:etiology; D008659:Metabolic Diseases / Q000209:etiology; D017410:Practice Guidelines as Topic; D063189:Symptom Assessment; D013974:Thyroxine / Q000627:therapeutic use*
chemical_list: D013974:Thyroxine
keywords: Hypothyroidism; levothyroxine; thyroid; thyroid peroxidase antibodies; thyroid stimulating hormone